Article

Clarity Medical Systems obtains patent

Clarity Medical Systems Inc. has received a patent on optimizing vision correction procedures from the U.S. Patent and Trademark Office.

 

Pleasanton, CA-Clarity Medical Systems Inc. has received a patent on optimizing vision correction procedures from the U.S. Patent and Trademark Office.

The patent, which is a continuation of Clarity’s expanding HOLOS technology portfolio, includes the capture and display of high accuracy continuous intraoperative wavefront aberrometry.

“We believe this unique capability will provide the opportunity to deploy HOLOS to help ophthalmologists more rapidly and efficiently measure the patient’s refractive state during vision correction procedures, including assisting surgeons as a refractive guidance tool intraoperatively,” said Keith Mullowney, president and chief executive officer of Clarity.

Clarity’s first product application of the technology will be for refractive cataract surgery with HOLOS IntraOp-an intraoperative module that attaches to standard surgical microscopes to assist the surgeon in monitoring and confirming the refractive status of the patient’s eye throughout all phases of the surgical procedure.

 

For more articles in this issue of Ophthalmology Times eReport, click here.

 

To receive weekly clinical news and updates in ophthalmology, subscribe to the Ophthalmology Times eReport.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Parag Majmudar, MD, on bridging the gap between residency and real-world practice
Brett Bielory, MD, discusses his poster at the ASCRS annual meeting, which focuses on an under-diagnosed corneal pathology: neurotrophic keratitis.
(Image credit: Ophthalmology Times) Oluwatosin U. Smith talks Glaukomtecken
ASCRS 2025: Eva Kim, MD, discusses implantable collamer lenses and high myopia.
© 2025 MJH Life Sciences

All rights reserved.